With 3 Granted Patents and 41 Pending, Small Pharma Is On Track To Be One Of Europe’s Biggest Psychedelic Companies Nov 19, 2021
Braxia CEO Dr. McIntyre Looks To Establish Framework For Psychedelic Therapeutic Advancement Nov 19, 2021
Synthesized Non-Hallucinogenic LSD Puts BetterLife Pharma on Psychedelic Investors Radar Nov 18, 2021
InMed Pharmaceuticals Sees Historic Volume As It Enters Commercial Stage Of Bulk Cannabinoid Sales Nov 18, 2021
PharmaDrug Provides Research Results and Initiates IND-Enabling Studies for Cepharanthine in the Treatment of Multiple… Nov 18, 2021
